Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Icon plc (ICLR)
NASDAQ:ICLR
Holding ICLR?
Track your performance easily
ICLR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$183.38 - $347.72
Previous Close$195.6
Volume1.84M
Average Volume (3M)1.09M
Market Cap
$16.15B
Enterprise Value$19.71B
Total Cash (Recent Filing)$380.06M
Total Debt (Recent Filing)$3.94B
Price to Earnings (P/E)21.8
Beta1.47
Next Earnings
Feb 19, 2025EPS Estimate
$3.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)8.98
Shares Outstanding82,495,086
10 Day Avg. Volume1,887,280
30 Day Avg. Volume1,090,806
Standard Deviation0.10
R-Squared0.45
Alpha-0.00336
Financial Highlights & Ratios
Price to Book (P/B)1.75
Price to Sales (P/S)1.90
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.08
Enterprise Value/Gross Profit8.21
Enterprise Value/Ebitda27.79
Forecast
1Y Price Target
$278.10Price Target Upside36.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Icon News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceICLR's backlog grew significantly, with a 9.4% year-over-year increase to $24.3 billion, indicating strong future business prospects.
Market PositionICLR is a market leader in the contract research organization (CRO) space, particularly the late-stage clinical space, and has solidified its position with strategic acquisitions.
Strategic PartnershipsThe new strategic partnership award ICLR received from a top 10 pharma supports the long-term thesis and is expected to accelerate business wins.
Bears Say
Client RelationsICLR's softer business-to-business ratio reflects slower ramp-up of new project work with its largest customers, including JNJ and PFE.
Financial PerformanceICLR reported Q3:24 earnings that missed estimates across the board, due to headwinds from customer budget cuts, lower than anticipated vaccine-related activity, and continued softness from biotech customers.
Sector ChallengesBiotech weakness is identified as the most challenging aspect of ICLR's business, with slower study startups and more cautious spending.
---
Ownership Overview
1.96% Insiders
29.66% Mutual Funds
39.02% Other Institutional Investors
28.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICLR FAQ
What was Icon plc’s price range in the past 12 months?
Icon plc lowest stock price was $183.38 and its highest was $347.72 in the past 12 months.
What is Icon plc’s market cap?
Currently, no data Available
When is Icon plc’s upcoming earnings report date?
Icon plc’s upcoming earnings report date is Feb 19, 2025 which is in 90 days.
How were Icon plc’s earnings last quarter?
Icon plc released its earnings results on Oct 23, 2024. The company reported $3.35 earnings per share for the quarter, missing the consensus estimate of $3.851 by -$0.501.
Is Icon plc overvalued?
According to Wall Street analysts Icon plc’s price is currently Undervalued.
Does Icon plc pay dividends?
Icon plc does not currently pay dividends.
What is Icon plc’s EPS estimate?
Icon plc’s EPS estimate is $3.42.
How many shares outstanding does Icon plc have?
Icon plc has 82,559,364 shares outstanding.
What happened to Icon plc’s price movement after its last earnings report?
Icon plc reported an EPS of $3.35 in its last earnings report, missing expectations of $3.851. Following the earnings report the stock price went down -21.025%.
Which hedge fund is a major shareholder of Icon plc?
Among the largest hedge funds holding Icon plc’s share is First Pacific Advisors LLC. It holds Icon plc’s shares valued at 102M.
---
Icon Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$278.10 (36.54% Upside)
$278.10 (36.54% Upside)
Blogger Sentiment
Bullish
ICLR Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 2.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.54%
12-Months-Change
Fundamentals
Return on Equity
7.98%
Trailing 12-Months
Asset Growth
1.05%
Trailing 12-Months
Company Description
Icon plc
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
---
ICLR Company Deck
---
ICLR Earnings Call
Q3 2024
0:00 / 0:00
---
ICLR Stock 12 Month Forecast
Average Price Target
$278.10
▲(36.54% Upside)
Technical Analysis
Best Analysts Covering ICLR
1 Year
1 Year Success Rate
20/30 ratings generated profit
1 Year Average Return
+6.10%
reiterated a buy rating 29 days ago
Copying Ann Hynes's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +6.10% per trade.
---